Significant downregulation of miR-98-5p in KRAS mutant CRC tissues compared to wild-type was observed, suggesting a molecular signature that could enhance CRC molecular understanding and aid in identifying novel biomarkers [62]. This evidence concerns the gene KRAS and colorectal carcinoma.